Functional activity of the muscarinic positive allosteric modulator VU319 during a Phase 1 Single Ascending Dose study

Authors:
  • ACAlexander Conley
    Alexander Conley
  • AKAlexandra Key
    Alexandra Key
  • JBJennifer Blackford
    Jennifer Blackford
  • JRJerri Rook
    Jerri Rook
  • JCJeffrey Conn
    Jeffrey Conn
  • CLCraig Lindsley
    Craig Lindsley
  • CJCarrie Jones
    Carrie Jones
  • PNPaul Newhouse
    Paul Newhouse

Abstract
No abstract available